High Prevalence of Macrolide-resistance and Molecular Characterization of Streptococcus pyogenes Isolates Circulating in China from 2009 to 2016
Related Experiment Video
Updated: Feb 27, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Binghuai Lu1, Yujie Fang2,3, Yanyan Fan4
1Department of Laboratory Medicine, Civil Aviation General Hospital, Peking University Civil Aviation School of Clinical MedicineBeijing, China.
Abstract:
Streptococcus pyogenes, or group A Streptococcus, is a pathogen responsible for a wide range of clinical manifestations, from mild skin and soft tissue infections and pharyngitis to severe diseases. Its epidemiological characteristics should be comprehensively under surveillance for regulating the national prevention and treatment practice. Herein, a total of 140 S. pyogenes, including 38 invasive and 102 noninvasive isolates, were collected from infected patients in 10 tertiary general hospitals from 7 cities/provinces in China during the years 2009-2016. All strains were characterized by classical and molecular techniques for its emm types/subtypes, virulent factors and antibiotic resistance profiling. Of 140 isolates, 15 distinct emm types and 31 subtypes were detected, dominated by emm12 (60 isolates, 42.9%), emm1(43, 30.7%), and emm89 (10, 7.1%), and 8 new emm variant subtypes were identified. All strains, invasive or not, harbored the superantigenic genes, speB and slo. The other virulence genes, smeZ, speF, and speC accounted for 96.4, 91.4, and 87.1% of collected isolates, respectively. Further multilocus sequence typing (MLST) placed all strains into 22 individual sequence types (STs), including 4 newly-identified STs (11, 7.9%). All isolates were phenotypically susceptible to penicillin, ampicillin, cefotaxime, and vancomycin, whereas 131(93.5%), 132(94.2%), and 121(86.4%) were resistant to erythromycin, clindamycin, and tetracycline, respectively. Our study highlights high genotypic diversity and high prevalence of macrolide resistance of S. pyogenes among clinical isolates circulating in China.
Insights
This study analyzed 140 Streptococcus pyogenes clinical isolates in China, revealing high genetic diversity and significant macrolide resistance. Surveillance of these characteristics is crucial for public health prevention and treatment strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Streptococcus pyogenes (group A Streptococcus) causes diverse infections, from mild to severe.
- Understanding its epidemiology is vital for national prevention and treatment practices.
- Data on circulating strains in China is essential for targeted interventions.
Purpose of the Study:
- To characterize the emm types, virulence factors, and antibiotic resistance of S. pyogenes clinical isolates in China.
- To assess the genotypic diversity and prevalence of resistance among these isolates.
- To provide data for national surveillance and inform clinical practice.
Main Methods:
- Collected 140 S. pyogenes isolates (38 invasive, 102 noninvasive) from 10 hospitals in China (2009-2016).
- Utilized classical and molecular techniques for emm typing, virulence gene detection, and antibiotic resistance profiling.
- Performed multilocus sequence typing (MLST) to determine sequence types (STs).
Main Results:
- Identified 15 emm types and 31 subtypes, with emm12, emm1, and emm89 dominating. Identified 8 new emm variant subtypes.
- All strains harbored speB and slo; high prevalence of smeZ, speF, and speC was observed.
- Detected 22 STs, including 4 new ones. High resistance rates to erythromycin (93.5%), clindamycin (94.2%), and tetracycline (86.4%) were found, while susceptibility to penicillin and vancomycin remained high.
Conclusions:
- S. pyogenes in China exhibits significant genotypic diversity.
- High prevalence of macrolide and tetracycline resistance is a major concern.
- Continuous surveillance and updated treatment guidelines are necessary to combat S. pyogenes infections.

